Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Kidney International|May 23, 2021
Phosphate meeting cholesterol-consequences for cardiovascular disease in chronic kidney disease?Lucie Hénaut, Ziad A Massy
Advances in Chronic Kidney Disease|May 26, 2018
Magnesium as a Calcification InhibitorLucie Hénaut, Ziad A Massy
Seminars in Nephrology|May 14, 2018
Updates on the Mechanisms and the Care of Cardiovascular Calcification in Chronic Kidney DiseaseLucie Hénaut, Jean-Marc Chillon, Saïd Kamel, et al.
Seminars in Nephrology|December 16, 2014
Calcium-sensing receptor activation in chronic kidney disease: effects beyond parathyroid hormone controlZiad A Massy, Lucie Hénaut, Tobias E Larsson, et al.
Frontiers in Cardiovascular Medicine|November 24, 2025
Insights into preclinical models of calcific aortic valve disease and their translational potentialIsabelle Lafosse, Romuald Mentaverri, Carine Avondo, et al.
Toxins|May 31, 2018
The Impact of Uremic Toxins on Vascular Smooth Muscle Cell FunctionLucie Hénaut, Aurélien Mary, Jean-Marc Chillon, et al.
Clinical Kidney Journal|March 14, 2025
Valvular calcification in chronic kidney disease: new insights from recent clinical and preclinical studiesLucie Hénaut, Alexandre Candellier, Sharon Huish, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 21, 2020
Aortic stenosis in patients with kidney failure: Is there an advantage for a <i>PD-first policy</i>?Alexandre Candellier, Lucie Hénaut, Johann Morelle, et al.
Expert Opinion on Therapeutic Targets|January 21, 2016
Targeting local vascular and systemic consequences of inflammation on vascular and cardiac valve calcificationLucie Hénaut, Maria Dolores Sanchez-Nino, Gonzalo Aldamiz-Echevarría Castillo, et al.
Frontiers in Cardiovascular Medicine|October 10, 2025
Macrophages as key modulators of calcific aortic valve diseaseNervana Issa, Gérémy Blot, Alexandre Candellier, et al.
Pageof 3